United States
Cases, + 102,004 = 27,229.862
Dearth, +3,589 = 474,423 (0.14% of population)
Hospitalizations, 69,283 (14,369, 4,643)
Vaccine doses since 14th December, 50, 641,884
First dose, 37,056,122
Booster doses, 13,082,172 (4.08%)
US COVID-19 Cases Caused by Variants
https://www.cdc.gov/coronavirus/2019-ncov/transmission/variant-cases.html
US B.1.1.7 dashboard
https://www.helix.com/pages/helix-covid-19-surveillance-dashboard
Florida
California
Georgia
Texas
CDC data
https://covid.cdc.gov/covid-data-tracker/#trends_dailytrendscases
Past 7 days
https://www.washingtonpost.com/graphics/2020/national/coronavirus-us-cases-deaths/?itid=sf_coronavirus
New daily reported cases, down 22.1%
New daily reported deaths, down 5.8%
CoViD related hospitalizations, down 17.8%
Test positivity rate, 5.8%
https://covidtracking.com/data
United kingdom
UK data
Cases, + 13,308 = 4,027,106
Deaths, + 621 = 116,908 (0.18% of population)
Vaccinations
First dose, 14,556,827
Second dose, 534,869
https://coronavirus.data.gov.uk/details/cases
Tracker app data
https://covid.joinzoe.com/data#levels-over-time
Oxford University extends COVID-19 vaccine study to children
https://www.ovg.ox.ac.uk/news/oxford-university-extends-covid-19-vaccine-study-to-children
13th February
London, Southampton and Bristol
Safety and immune responses in children and young adults
Ages, 6 to 17 years
Single-blind, randomised phase II trial
N = 300 volunteers
Vaccine group, n = 240
Control group, n = 60, meningitis vaccine
Safe and gives a sore arm
Andrew Pollard
Professor of Paediatric Infection and Immunity, and Chief Investigator on the Oxford vaccine trial
While most children are relatively unaffected by coronavirus and are unlikely to become unwell with the infection,
it is important to establish the safety and immune response to the vaccine in children and young people as some children may benefit from vaccination.
These new trials will extend our understanding of control of SARS-CoV2 to younger age groups
Starting trials for younger children this spring
Pfizer
Moderna
Janssen
Source